Đang chuẩn bị liên kết để tải về tài liệu:
A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Gastric cancer (GC) is one of the leading causes of cancer-related deaths worldwide. Human epidermal growth factor receptor 2 (HER2) amplification occurs in approximately 13–23% of all GC cases and patients with HER2 overexpression exhibit a poor prognosis. |

TÀI LIỆU LIÊN QUAN

Tissue Penetration of a novel spectinamide antibiotic for the treatment of tuberculosis

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases

Characterization of a novel bioflocculant from a marine bacterium and its application in dye wastewater treatment

Ebook Novel catalysts in advanced oxidation of organic pollutants

Ebook Novel catalysts in advanced oxidation of organic pollutants

HEAT TREATMENT – CONVENTIONAL AND NOVEL APPLICATIONS

báo cáo hóa học:" Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q™), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women"

A novel mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome: A late-onset of the fatal cardiac conduction deficit and cardiomyopathy accompanying long-term rGH treatment

CYP1A2 – a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma